Why Moderna Stock Is Rising Today

Shares of Moderna (NASDAQ: MRNA) were rising 2.6% higher as of 11:25 a.m. EDT on Tuesday. The gain came after the company announced that the European Medicines Agency authorized a third dose of COVID-19 vaccine Spikevax to severely immunocompromised individuals ages 12 and older.

The modest gain for the vaccine stock today reflects the muted impact that the EMA decision will make for Moderna. Authorizing the third dose for only severely immunocompromised individuals limits the market significantly.

Image source: Getty Images.

Continue reading


Source Fool.com